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scale of and demonstrate improvement in patient harms. Pressure ulcer (PU)
monitoring systems have been introduced across NHS in-patient facilities in En-
gland, including the Safety Thermometer (STh) (prevalence), Incident Reporting
Systems (IRS) and the Strategic Executive Information System (STEIS) for serious
incidents. This is the first of two related papers considering PU monitoring sys-
tems across NHS in-patient facilities in England and focusses on a Wound Audit
(PUWA) to assess the accuracy of these systems. Part 2 of this work and recom-
mendations are reported pp *-*.
The PUWA was undertaken in line with ‘gold-standard’ PU prevalence methods
in a stratified random sample of NHS Trusts; 24/34 (72.7%) invited NHS Trusts
participated, from which 121 randomly selected wards and 2239 patients agreed
to participate.
Prevalence of existing PUs: The PUWA identified 160 (7.1%) patients with an ex-
isting PU, compared to 105 (4.7%) on STh. STh had a weighted sensitivity of
48.2% (95%CI 35.4%e56.7%) and weighted specificity of 99.0% (95%CI 98.99%e
99.01%).
Existing/healed PUs: The PUWA identified 189 (8.4%) patients with an existing/
healed PU compared to 135 (6.0%) on IRS. IRS had an unweighted sensitivity of 53.4%
(95%CI 46.3%e60.4%) and unweighted specificity of 98.3% (95%CI 97.7%e98.8%). 83 pa-
tients had one or more potentially serious PU on PUWA and 8 (9.6%) of these patients
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OA, Present on admission; HA, Hospital acquired.
.uk (I.L. Smith).
11.001
ished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
nd/4.0/).
4 I.L. Smith et al.The results identified high levels of under-reporting for all systems and highlighted
data capture challenges, including the use of clinical staff to inform national moni-
toring systems and the completeness of clinical records for PUs.
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In efforts to minimise patient harm in health-care
systems the measurement of adverse events
including pressure ulcers has been undertaken to
assess the burden and scale of patient harm and
attempt to measure improvement [1e7].
In line with international debate and policy, a
number of initiatives have been introduced
throughout the NHS in England to facilitate
improved care quality and patient safety. They are
set against changes to the NHS structure in En-
gland, which encompasses two main functions; the
first is to commission health services which deliver
high quality patient care and improved outcomes
and the second is to provide this care [8]. There-
fore both commissioners and care providers are
important stakeholders for PU monitoring.
The importance of collecting and learning from
patient safety incident data was highlighted by ‘An
organisation with a memory’ [9] and subsequent
implementationpublication ‘Building a Safer NHS for
patients’ [10], providing the impetus for theNational
Patient Safety Agency and the National Reporting
and Learning System (NRLS) established in 2003 to
encourage national reporting of patient safety in-
cidents to facilitate widespread learning and
establish priorities for patient safety [11]. Subse-
quently, an NHS Outcomes Framework was devel-
oped to provide national-level accountability for
the delivery of outcomes and facilitate quality
improvement and includes PUs [12], with oper-
ationalization through theCommissioning forQuality
and Innovation (CQUIN) framework [13,14]with local
target setting for the reduction of avoidable harm.
The policy initiatives have led to the develop-
ment of data collection systems and quality met-
rics including: the Safety Thermometer (STh) [15]
which includes assessing PU prevalence monthly;
Incident Reporting Systems (IRS) to facilitate data
reporting to the NRLS [11], and NHS England’s web-
based serious incident management system, the
Strategic Executive Information System (STEIS) for
the reporting of serious incidents (SIs) [16].
The Quality Observatory is an organisation that
was set up to enable local benchmarking and the
development of metrics [17]. The STh is a nation-
ally co-ordinated measurement tool to supportpatient safety improvement in the NHS [15]. While
it is a voluntary scheme it is incentivised via
CQUINs and most NHS Trusts participate. Data
collection is undertaken locally on one specific day
of each month by front line nursing teams, for all
NHS funded patients. Anonymous data is then
uploaded to the national database, providing a
point prevalence of existing PUs, which is pre-
sented as the percentage of all in-patients with a
PU on the STh census date.
IRS’s, using software packages including Datix
[18] and Ulysses [19] are locally held databases
capturing patient identifiable reported incidents
of harm including PUs. Most Trusts routinely up-
load anonymised IRS data to the NRLS on a
monthly basis, though direct reporting to the NRLS
can be undertaken [11]. Locally the actual
reporting of incidents is encouraged to be under-
taken as near to the time of the incident as
possible. Incident monitoring data provides either
a simple count of the number of PU incidents per
month, a measure of the incidence of PUs as a
proportion of the number of patients admitted to
hospital in that month, or a measure of the
number of PUs per 1000 bed days in that month.
For SIs there are additional requirements,
including reporting the incident to STEIS (without
patient or staff names) the NRLS, the Care Quality
Commission (CQC) and other bodies as appropriate
[16].
There has been a number of difficulties in the
definitions (Table 1) and implementation of quality
metrics including:
 Interchangeable use of the terms prevalence,
incidence and incidents despite their
differences.
 Poor coding of pressure ulcers in healthcare
records.
 Lack of clear national guidance for the
reporting of pressure ulcers (e.g. type of ulcer
to be reported, classification system to be
used) which has led to inconsistent reporting
across the country [20].
 The introduction of the terms ‘Old’ and ‘New’
pressure ulcers in the STh methodology,
whereby pressure ulcers present within 72 of
admission are classified as ‘Old’.
Table 1 Definitions of data collected on PU monitoring systems.
Safety thermometer Incident reporting
system/strategic
executive information
system
Pressure ulcer and wound
audit (PUWA)
Classification
2 U As per local Trust policy
(see questionnaire results)
U
3 U U
4 U U
Unstageable X U
DTI X U
Origin
Present on admission
(POA)
A pressure ulcer that was
present when the patient
came under your care, or
developed within 72 h of
admission to your
organisationa
Recorded at the time of
admission as per trusts
local classification
systemc
Recorded in the patient’s
clinical record as category
2, 3, 4, U or DTI at the
time of admission
Hospital Acquired (HA) A pressure ulcer that
developed 72 h or more
after the patient was
admitted to your
organisationb
Not POA A pressure ulcer which
was not POA
Pressure ulcer data recorded
Current pressure ulcers For new and Old the
classification of the worst
pressure ulcer should be
reported.
All data recorded for a
patient during their
current admission should
be recorded, including all
classifications of ulcers
from all reports listed.
 ‘Current category’
recorded as the cate-
gory of PU observed at
the PUWA skin
assessment
 ‘Worst category’
recorded as the worst
categoryd reported in
the patient’s clinical
records during this
admission.
Healed pressure ulcerse N/A  ‘Worst category’
recorded as the worst
categoryd reported in
the patient’s clinical
records during this
admission.
a This is the definition for a ‘Old’ ulcer on the Safety Thermometer.
b This is the definition for a ‘New’ ulcer on the Safety Thermometer.
c Questionnaire responses indicated that only 10 use on admission definition; 12 use within 72 h of admission.
d Severity of classification from worst to best is 4, 3, Unstageable, DTI, 2.
e Defined as complete re-epithelialisation in the absence of a scab including normal or erythematous skin.
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and comparisons of data between NHS organi-
sations [20].
 Concern regarding inappropriate interpretation
of data by Commissioners in their assessment
of Trust performance, with (in some cases)
associated financial penalties [21].The Tissue Viability Society (TVS), therefore
agreed to fund a project, supported by the NHS
England Safety Team to inform the development ofa standardised approach to pressure ulcer moni-
toring to underpin implementation of the NHS
Outcomes Framework.
2. Aim
The project aimed to assess the accuracy of cur-
rent PU monitoring systems, against a ‘gold stan-
dard’ Pressure Ulcer/Wound Audit (PUWA) and if
appropriate, develop proposals for a standardised
approach to PU monitoring. The project comprised
6 I.L. Smith et al.two related pieces of work 1) a PU/Wound Audit
and 2) a survey of PU monitoring systems [22]
(reported pp *-*). This paper reports the results
of the PUWA.3. Methods
NHS Trusts providing community, secondary and
tertiary care in-patient services, who participate
in STh data submissions to the Health and Social
Care Information Centre (HSCIC), were identified
through stratified random sampling. Stratification
factors included: STh prevalence rates (i.e. normal
range, high and low outliers as defined by the NHS
Quality Observatory) taken from the May 2014 STh
data; size of in-patient facility (468 beds,
468 < beds < 780, 780 beds), and geographical
location (north: North West, North East, Yorkshire
and the Humber, East Midlands, West Midlands,
south: South West, South East, London, East of
England). The study was conducted on each Trusts
STh census date in October 2014.
Assenting NHS Trusts provided a list of all wards
and number of beds from which a range of speci-
alities (excluding psychiatric, obstetrics, paediat-
rics and day case care environments) were
randomly selected to participate.
Participating wards were given no prior warning
that they would be audited using the PUWA.
Following verbal confirmation by the ward that
they had completed their STh submission, the
nurse in charge was informed about the PUWA.
Patients were informed that a national audit study
was in progress to check the accuracy of nurses
reporting of PUs, and that this involved a visual
skin assessment of their pressure area skin sites
and looking in their clinical records. They were
reassured that their data would remain anonymous
and their identity would not be disclosed in the
course of the analysis or final report. As such, due
to the nature of audits, ethical approval for this
study was not required however, verbal consent
for skin inspection was obtained in line with usual
clinical procedures and care.
The PUWA was conducted using ‘gold-standard’
PU prevalence methods and included a full skin
inspection of all consenting in-patients on the
participating wards by two independent qualified
clinical members of staff who were blind to the
STh submission data. Skin was assessed using the
full international PU classification [23], with
additional skin status and wound descriptors
including the wound type (surgical/traumatic/leg
ulcer/dermatological/ischaemic/other) and ulcer
type (PU/IAD/Device ulcer/DFU on heel/CombinedPU/IAD) with the origin and current and worst
ulcer PU classification (during the current stay) if
applicable. A record review was conducted to
identify any healed wounds and PU(s) which had
been present during their current hospital stay, in
addition to the most severe category and the origin
of any PUs. The PUWA data collection was
designed to obtain data on existing and healed
ulcers to use for the assessment of the accuracy of
the STh, IRS and STEIS; further data on other
wounds were also collected to explore the possi-
bility of misclassification on the monitoring sys-
tems. The PUWA data was recorded in an audit
booklet and then concealed using an adhesive seal
before handing to a third nurse/auditor who then
accessed the STh data returns and the IRS and
STEIS databases and recorded all incidents re-
ported for the patient’s current admission. In
order to ensure the correct STh, IRS and STEIS data
was obtained, the patients hospital/NHS ID, Date
of birth, initials and name of ward were recorded
on the front of the booklet; these data were
removed prior to transfer to Leeds Institute for
Clinical Trials Research (LICTR) in order to main-
tain anonymity. The hospital name, ward speci-
ality and admission date were also recorded on the
booklet. The PUWA data collection was piloted
prior to finalising the booklet to ensure it was us-
able and provided the relevant information for
analysis. The assessors, were members of the Tis-
sue Viability Team or ward based expert nurses
and experienced in undertaking skin assessment
and were given no additional training prior to the
audit taking place.
The STh National methodology requires Trusts
to record the worst Category of ‘Old’ and worst
Category of ‘New’ existing PUs using the NPUAP/
EPUAP 2009 [23] classification of Category 2e4.
‘Old’ is defined by the STh [15] as ‘a pressure
ulcer that was present when the patient came
under your care, or developed within 72 h of
admission to your organisation’ and ‘New’ as ‘a
pressure that developed 72 h or more after the
patient was admitted to your organisation’. The
skin sites affected are not reported and only a
maximum of 2 PUs (one per origin) per patient can
be reported. Therefore the STh data collected as
part of the audit included whether a pressure
ulcer was reported on the STh October 2014 sub-
mission and, if so, the category for ‘old’ and/or
‘new’ ulcers.
The incident reporting systems (IRS and STEIS)
were checked and the following data recorded
from the patient’s current admission: skin site,
wound type, PU classification (category 2 or
above), and whether the PU was present on
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may include multiple reports for the same PU and
the audit booklet was designed to collect this
information.
3.1. Analysis
For all analyses, PUs included all reported ulcers
classified as ‘PU’, ‘combined PU/incontinence
associated dermatitis (IAD)’ or ‘device ulcer’.
Diabetic foot ulcers or other wounds (e.g. IAD,
surgical) are referred to as ‘other’ wounds. Data
summaries and comparisons of the STh data with
the PUWA data included only existing PUs, in line
with the STh reporting requirements. Data sum-
maries and comparisons of IRS and STEIS data with
the PUWA data included both current and healed
PUs to reflect the incident data captured by these
systems.
The sensitivity of the data source is defined as
its ability to report that a PU is present when the
patient is confirmed to have a PU via the PUWA
data [24]. The specificity of the data source is
defined as its ability to report that a PU is not
present when the patient is confirmed to not have
a PU via the PUWA data [24].
The sensitivity and specificity of the STh and IRS
have been estimated in reference to the ‘gold
standard’ PUWA. For the STh, weighted estimates
of the sensitivity and specificity for current PUs
were calculated using data provided by the NHS
Quality Observatory from October 2014 to coincide
with the date of the audit. The weighted sensi-
tivity and specificity estimates provide a measure
of the accuracy of the STh across the whole of the
NHS in England taking into account the stratified
sampling approach used and the corresponding
likelihood of being reported on the STh submission
in October 2014 within each stratum [25].
The estimate of the prevalence of category 2
and above PUs is weighted to take into account the
proportion of beds within the corresponding com-
bination of stratification factors from the total
population, and the number of patients assessed
within our sample for the same combination of
stratification factors using October 2014 data
provided by the Quality Observatory.
The IRS was assessed using unweighted esti-
mates of the sensitivity and specificity for both
current and healed pressure ulcers reported on
PUWA. The reason that these estimates are un-
weighted is because pre-existing information
about the probability of being recorded on the IRS
is unavailable. Therefore the sensitivity and
specificity estimates for the IRS represent thesample observed in this study rather than across
the whole of NHS in England.
3.2. Sample size
The audit sample size calculation is based on pa-
tient level data to ensure a direct comparison of
the STh with the PUWA. A total of 2614 patients
were required to estimate the sensitivity of the
STh to within a precision of 7% (corresponding to
the half width of the 95% confidence interval),
assuming a true prevalence of category 2 and
above PUs of 6.3% [26], sensitivity of 70% (based on
local audit work), and 5% significance level. As this
is a point prevalence audit there was no require-
ment to adjust for loss to follow up.
It was acknowledged throughout analysis that
data could not be verified with Trusts and, as such,
only limited data validation was possible.4. Results
4.1. PUWA
A total of 34 hospital NHS Trusts in England UK
were invited to participate in the project and 24
(70.6%) agreed. From the participating Trusts 121
wards were randomly selected from a range of
specialities with a total bed-base of 2468 beds,
from which 2239 patients were fully assessed
(Fig. 1). The number of patients fully assessed at
each Trust ranged from 14 to 174. The length of
stay for the current admission could be calculated
for 2203 (98.4%) patients; the mean (s.d.) length of
stay was 14.7 (22.13) days and ranged from 0 to
286 days with a median of 8 days.
There were 524 (23.4%) in-patients with an
existing and/or healed PU or wound, including 154
(6.9%) patients with PU(s), 35 (1.6%) patients with
both PU(s) and wound(s) and 335 (14.4%) with
wound(s) only (Table 2). The weighted prevalence
of existing PUs was 6.6% (95% CI 5.3%e8.0%).
4.2. Safety thermometer
There were 184 patients reported to have one or
more existing PUs on the STh and/or PUWA (Fig. 2).
The PUWA identified 160 (7.1%) and the STh data
return identified 105 (4.7%) patients as having at
least one existing pressure ulcer. Of those reported
on the PUWA, half (81/160, (50.6%)) were reported
on the STh. A further 24 patients identified by the
STh as having a PU were not reported by the PUWA,
including 10 patients reported as having an ‘other’
8 I.L. Smith et al.wound and 14 patients assessed as having no PU or
wound on the PUWA.
The weighted sensitivity estimate for the STh
was 48.2% (95% CI 35.4%e56.7%) and the weighted
specificity estimate was 99.0% (95% CI 99.0%e
99.0%). That is, there is a weighted estimate that
48.2% of patients with an existing PU are correctly
reported as having a PU and 99.0% of patients
without an existing PU are correctly not reported
on the STh submission.
Of the 184 patients reported to have one or
more existing PU on the PUWA and/or the STh, 129
(70.1%) patients had a POA/‘Old’ PU and 67 (36.4%)
had a HA/’New’ PU reported. The levels of under-
reporting were more than 44% for both POA (44.2%)
and HA (52.2%) ulcers (Table 3). However, 45 (90%)
patients with PUs reported as being POA by PUWA
were also reported by STh as ‘Old’, whereas, 16
(64%) reported as having HA PU(s) on PUWA were
reported by STh as ‘New’. Under-reporting for all
Categories of PU were also observed. However,
where PUs are reported by both the PUWA and
STh, there appears to be an accurate level of
reporting of the category of PU in the STh, though
numbers are small (Table 3).
4.3. Incident reporting system
A total of 223 patients were reported to have one
or more existing/healed PU/incident reported on
the PUWA and/or IRS (Fig. 3). The PUWA identified
189 (8.4%) and the IRS data return identified 135
(6.0%) patients as having at least one existing/
healed/incident report of pressure ulcer. Of those
reported on the PUWA, approximately half (101/
189, 53.4%) were reported on the IRS, whilst 34 of
the patients reported by IRS were not reported byFig. 1 Particthe PUWA including 11 patients reported as having
an ‘other’ wound, and 23 assessed as having no
existing or healed PU or wound. The number of
reports listed for each skin site on the IRS ranged
from 1 report to 3 reports.
The IRS has an unweighted sensitivity of 53.4%
(95% CI 46.3%e60.4%) and an unweighted speci-
ficity of 98.3% (95% CI 97.7%e98.8%). That is, 53.4%
of patients with an existing/healed PU were
correctly reported on the IRS as having had a PU
incident during that hospital admission and 98.3%
of patients without an existing/healed PU were
correctly not reported as having a PU on the IRS in
the population sampled.
The 223 patients with a PU reported on PUWA
and/or the IRS had a total of 330 skin sites with a
PU reported, of which only 101 (30.6%) were re-
ported on both data sources. There was a slightly
higher proportion of under-reporting on IRS for HA
PUs (68.0% (51/75)) compared to POA PUs (55.8%
(87/156)), whilst there was a high accuracy of
reporting for the origin (79.2% (80/101)) for PUs
reported on the same skin site by both data
sources.
There were high levels of under-reporting on IRS
for all PU Categories (Table 4) (67.7% (90/133)
Category 2, 45.3% (29/64) Category 3, 60.0% (12/
20) Category 4, 43.8% (7/16) Unstageable, 63.6%
(7/11) DTI). However, further investigation indi-
cated that where PUs were reported on the same
skin site by both data sources (N ¼ 101), there was
accurate reporting of category 2e4 PUs recorded
on the IRS (83.7% (36/43) Category 2, 60.0% (21/
35) Category 3, 75.0% (6/8) Category 4).
Further consideration was given to misclassifi-
cation of wound types (Table 5). A total of 555
patients had a reported PU or wound on PUWAipant flow.
Table 2 Data reported on pressure ulcer and wound audit.
Speciality Total
Medical 813 (36.3%)
Surgical 518 (23.1%)
Rehabilitation/intermediate
care
186 (8.3%)
Orthopaedics and trauma 195 (8.7%)
Oncology 113 (5.0%)
Critical care 28 (1.3%)
Specialist tertiary service 98 (4.4%)
Cardiology 13 (0.6%)
Emergency 2 (0.1%)
Gynaecology 19 (0.8%)
Haematology 11 (0.5%)
Spinal Injuries 19 (0.8%)
Urology 18 (0.8%)
Other 172 (7.7%)
Missing 34 (1.5%)
Total 2239 (100.0%)
Existing and/or healed Existing
Number of patients with PUs 189 (8.4%) 160 (7.1%)
Number of patients with PU and/or wound
PU(s) only 154 (6.9%) 135 (6.0%)
PU(s) and Wound(s) 35 (1.6%) 25 (1.1%)
Wound(s) only 335 (15.0%) 302 (13.5%)
None reported 1715 (76.6%) 1777 (79.4%)
Number of patients with IAD 110 (4.9%) 91 (4.1%)
Total number of pressure
ulcers
250 207
Mean (SD) 1.3 (0.65) 1.3 (0.66)
Median (Range) 1.0 (1.0, 5.0) 1.0 (1.0, 5.0)
Types of pressure ulcers
PU 225 (53.2%) 187 (90.3%)
Combined PU/IAD 11 (4.4%) 11 (5.3%)
Device Ulcer 14 (5.6%) 9 (4.3%)
Categories of ulcers
Category 2 133 (53.2%) 105 (50.7%)
Category 3 64 (25.6%) 56 (27.1%)
Category 4 20 (8.0%) 18 (8.7%)
Unstageable 16 (6.4%) 15 (7.2%)
DTI 11 (4.4%) 11 (5.3%)
Missing 6 (2.4%) 2 (1.0%)
Total number of wounds 462 405
Mean (SD) 1.2 (0.56) 1.2 (0.55)
Median (Range) 1.0 (1.0, 6.0) 1.0 (1.0, 5.0)
Types of wounds on ‘pressure areas’
Surgical wound 177 (38.3%) 161 (39.8%)
Traumatic wound 59 (12.8%) 48 (11.9%)
Leg ulcer wound 11 (2.4%) 11 (2.7%)
Dermatological wound 40 (8.7%) 40 (9.9%)
Ischemic wound 2 (0.4%) 2 (0.5%)
IAD 141 (30.5%) 117 (28.9%)
DFU on heel 7 (1.5%) 7 (1.7%)
Other wound 10 (2.2%) 4 (1.0%)
Missing 15 (3.2%) 15 (3.7%)
PU ¼ Pressure ulcer, IAD ¼ Incontinence associated dermatitis, SD ¼ Standard deviation,
DTI ¼ Deep tissue injury, DFU ¼ Diabetic foot ulcer.
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Fig. 3 Data reported on PUWA and IRS
(PUWA ¼ Pressure ulcer and wound audit; IRS ¼ Incident
reporting system).
Fig. 2 PU reporting on PUWA and STh
(PUWA ¼ Pressure ulcer and wound audit; STh ¼ Safety
thermometer).
10 I.L. Smith et al.and/or IRS, with a total of 810 PUs/wounds. There
were greater levels of under-reporting on the IRS
for IAD (91.5% (129/141)) and device ulcers (78.6%
(11/14)) compared to PUs (56.9% (128/225)) and
combined PU/IADs (63.6% (7/11)). It is also note-
worthy that the PUWA did not identify 39.5% (64/Table 3 Under reporting and agreement in classification
Category N (%) not reported on STh N
re
POA HA PO
2 28 (53.8%) 24 (72.7%) 20
3 14 (60.9%) 3 (37.5%) 4
4 4 (30.8%) 1 (50.0%) 5
Unstageable 6 (66.7%) 1 (100.0%) 0
DTI 3 (75.0%) 4 (66.7%) e
Category missing 2 (100.0%) 2 (100.0%) e
Total 57 (44.2%) 35 (52.2%) 29
PU ¼ Pressure ulcer, STh ¼ Safety thermometer, PUWA ¼ Pres
HA ¼ Hospital acquired, DTI ¼ Deep tissue injury.162) of PUs and 75.8% (25/33) of IADs reported on
the IRS at the corresponding skin site.
4.4. STEIS
Of the 2239 patients assessed as part of the PUWA,
83 had one or more potentially serious incident
recorded on the PUWA (defined as a PU classified
as category 3, 4, Unstageable or DTI). This
included 59 patients with a potentially serious
incident POA, 19 with HA, 1 with both POA and HA
and 4 where the origin was missing according to
PUWA. Of these 83 patients 8 (9.6%) patients were
reported on STEIS, including 1 POA, 6 HA and 1
missing (origin as reported on STEIS). In addition, 2
patients with a Category 2 PU and 1 patient with
no PU or wound identified on PUWA had an incident
reported on STEIS. The maximum number of re-
ports listed for each skin site on STEIS was 1. The
low levels of under-reporting to STEIS for all cat-
egories of PU are illustrated in Table 6.5. Discussion
The results of the PUWA add to the wider inter-
national debate relating to the use of adverse
event metrics data to assess improvement in pa-
tient safety and reductions in patient harms. The
safety and harm/adverse event literature has
previously assessed the level of agreement be-
tween raters and shown high levels of agreement
in the identification of adverse events (such as
medication errors, healthcare-acquired infections,
postoperative complications, delayed diagnoses,
fall-related injuries, pressure ulcers, etc) from
records, but poor reliability in the attribution of
the adverse event as preventable and non-
preventable [2732]. Researchers also report dif-
ficulty in the interpretation of adverse event dataof PUs for the STh vs PUWA.
(%) where ulcer classification agrees (for patients
ported on both PUWA and STh)
A HA
(83.3%) 7 (77.8%)
(44.4%) 3 (60.0%)
(55.6%) 1 (100.0%)
(0.0%) e
e
e
(63.0%) 11 (64.7%)
sure ulcer and wound audit, POA ¼ Present on admission,
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Audit of monitoring systems 11in terms of changes (or not) over time [1e7] and it
has been suggested that studies need to capture
specific adverse events that measure the impact of
implemented interventions, rather than continuing
to rely on broad heterogeneous measures such as
adverse events [1].
There is also a wider political agenda to utilise
routine clinical data to support improvements in
healthcare provision and in healthcare research
including clinical trials and quality improvement
[33,34]. The policy driver is to maximise the po-
tential use of available data for patient benefit
[35] and improve research efficiency and reduce
the costs of data capture for research and quality
improvement. However, in order to use routine
clinical data we need to consider data quality
including the completeness and accuracy of the
data and their impact on the findings of the
research [34]. We need to understand the level of
under-reporting in the clinical records, the level of
under-recording of clinical coders and the reli-
ability of the data (for example, diagnostic accu-
racy and classification of disease). Accurate
retrieval of adverse events from healthcare re-
cords has been explored [1], however there is a
question around whether adverse events such as
PUs are actually recorded in healthcare records.
Our research suggests that the reporting by clinical
staff of PU events, including severe PUs, to moni-
toring systems is not complete and further
research is required to understand whether there
are similar issues with the level of under reporting
in the clinical records.
The results of the PUWA highlight a number of
issues important to the challenges of data capture
using clinical staff to inform monitoring systems
and the completeness of clinical records for one
adverse event, pressure ulcers. The results from
the PUWA indicate high levels of under reporting of
PUs across all existing routine monitoring NHS
systems in England including STh, IRS and STEIS at
both the patient and skin site level as well as
failings in the clinical records. At the patient level,
high levels of under-reporting were observed,
whereby the PUWA identified patients with PUs not
reported on the monitoring systems illustrated by
the corresponding estimates of sensitivity. The
corresponding estimates of specificity were high,
although this is reflecting the nature of specificity
as its value depends on the low probability of being
reported on the monitoring systems together with
the large number of patients confirmed not to have
a PU on PUWA [24,36]. It is noteworthy that a
clinically significant minority of patients reported
on the STh and IRS monitoring systems as having a
PU harm were not identified by the PUWA audit
Table 5 Types of wounds reported on the PUWA and IRS.
PUWA Total
PU Combined
PU/IAD
Device
ulcer
IAD Other
wound
type*
Ulcer/
wound type
Missing
No
PU/wound
reported
IRS PU 89 (39.6%) 3 (27.3%) 1 (7.1%) 5 (3.5%) 0 (0.0%) 0 (0.0%) 64 (65.3%) 162 (20.0%)
Combined
PU/IAD
3 (1.3%) 1 (9.1%) 0 (0.0%) 2 (1.4%) 0 (0.0%) 0 (0.0%) 3 (3.1%) 9 (1.1%)
Device
ulcer
2 (0.9%) 0 (0.0%) 2 (14.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 6 (6.1%) 10 (1.2%)
IAD 3 (1.3%) 0 (0.0%) 0 (0.0%) 5 (3.5%) 0 (0.0%) 0 (0.0%) 25 (25.5%) 33 (4.1%)
Ulcer/
wound type
missing
0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.3%) 0 (0.0%) 0 (0.0%) 1 (0.1%)
No PU/
wound
reported
128
(56.9%)
7
(63.6%)
11
(78.6%)
129
(91.5%)
305
(99.7%)
15
(100.0%)
0
(0.0%)
595
(73.5%)
Total 225
(100.0%)
11
(100.0%)
14
(100.0%)
141
(100.0%)
306
(100.0%)
15
(100.0%)
98
(100.0%)
810
(100.0%)
The shaded cells correspond to agreement whilst the bold cells correspond to under-reporting.
PU ¼ Pressure ulcer, IRS ¼ Incident reporting system, PUWA ¼ Pressure ulcer and wound audit, IAD ¼ Incontinence associated
dermatitis.
12 I.L. Smith et al.team. This is of particular concern for the IRS data
where 34/135 (25.2%) patients reported as having
an ulcer on the IRS were not reported (existing or
healed) on the PUWA. This suggests difficulties in
identifying pressure ulcer harm from the clinical
record and that the submission of an incident
report to the IRS is not readily identifiable in the
patient record.
There were high levels of under-reporting for all
categories of PUs at the skin site level; particularly
category 2 PUs. Given the superficial nature of
these ulcers, poor recording in clinical records, the
potential time delay for the reporting and
recording on the monitoring systems and the sta-
tistical analysis at skin site level which required
both data sources to record the PU at the same
skin site, some differences were expected, though
not to the extent observed.
The high level of under-reporting of severe,
category 3 and 4 ulcers raises concerns on a num-
ber of levels. Such ulcers are a serious patient
harm, and the lack of awareness of the presence of
such harm suggests that local intelligence gath-
ering, handover reports and clinical records do not
provide readily available, accurate and accessible
information about patient status to the attending
clinical team or specialist teams undertaking sur-
veillance of PU harms. This is consistent with
research which identified deficits in patient to
staff and staff to staff communication of PU status[37]. Furthermore, the levels of under-reporting
on STEIS is not in line with previous suggestions
that the majority of organisations report category
3 and 4 ulcers as SIs [20].
The level of under-reporting of IAD and device
ulcers on IRS was higher compared to PUs, though
the number of device ulcers was small. The pro-
portion of device ulcers reported in the PUWA was
smaller than those reported in a previous American
study involving an acute medical centre population
where device ulcers accounted for 34.5% (39/113)
of HA PUs [38]. This can be explained by the in-
clusion of different patient populations and the
inclusion of stage 1 ulcers which accounted for
over a third of the device ulcers reported by Black
et al. [38].
It is reassuring that where the PUWA and
monitoring systems agreed on the presence of a
PU, good levels of accuracy of reporting were
observed for both the origin (i.e. ‘Old’/’New’ and
POA/HA) of the ulcer and its category. This is
consistent with studies of PU classification which
demonstrate good inter-rater reliability for the
EPUAP (1989), NPUAP (1989) and the NPUAP/
EPUAP (2009) classification systems [39]. There
were slightly more misclassifications in terms of
origin for HA ulcers, potentially reflecting differ-
ences in the POA/HA, ‘Old’/’New’ definitions.
To our knowledge this is the first study to
compare national PU monitoring systems. While
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Audit of monitoring systems 13the PU prevalence is lower than those reported in
previous studies (Pieper 2012) this can be
explained by the exclusion of category 1 ulcers;
the results are consistent with a recent multi-
centre prevalence study undertaken in UK NHS
hospitals, which observed a prevalence of 6.3% for
category 2 and above ulcers [26,40]. The findings
from this part 1 PUWA were considered alongside
the part 2 survey of PU monitoring systems (pp *-*)
and recommendations were developed and are
highlighted in the part 2 publication [22].
A methodology strength is the blinding of those
undertaking the PUWA to those obtaining STh, IRS
and STEIS information and vice-versa. This
required detailed planning and commitment from
sufficient numbers of staff with appropriate
experience to ensure data collection was accu-
rately undertaken on the STh census day. Even
with teams of three (2 conducting PUWA and 1
conducting review of STh, IRS, STEIS data sources)
undertaking data collection, it is acknowledged
that a fourth independent member of each team
would have been advantageous to conduct cross
referencing between data sources. This is partic-
ularly important given that the PUWA did not
identify a clinically important number of PUs
(N ¼ 64, 65.3%) and some IADs (N ¼ 25, 25.5%) that
were reported on the IRS. There are a number of
possible reasons for this including discrepancies
between skin sites identified (e.g. right heel
identified at PUWA and left heel recorded on IRS);
other recording errors (e.g. recording IRS data on
incorrect patient PUWA form, though 3 identifiers
were used), or difficulties in identifying incident
reports made to IRS in the patients clinical record.
Another methodological strength is the inclusion
of data relating to patient refusal rates, which are
not routinely reported in other prevalence studies.
The majority of refusals occurred in 1 Trust which
could be related to a lack of experience in un-
dertaking this type of work. These findings could
inform the approach used in future studies.6. Conclusion
Using a robust methodological approach we un-
dertook a PUWA in a stratified random sample of 24
NHS Trusts providing in-patient services for adult
patient populations in England to compare current
data sources including in-patient STh prevalence
data, and incident reporting to the IRS and STEIS.
The key finding was high levels of under-reporting
for all categories of PUs across all monitoring sys-
tems. The results add to the wider international
debate relating to the use of adverse event metrics
14 I.L. Smith et al.data to assess improvement in patient safety and
reductions in patient harms, highlighting a number
of issues including the use of clinical staff to
inform national monitoring systems and the
completeness of clinical records for case finding of
adverse events. Recommendations were devel-
oped from this and the complimentary survey of
PU monitoring systems and are highlighted in the
part 2 publication [22] (reported pp *-*).Conflict of interest statement
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